Endoscopic gastric tubulization for weight loss
Official title: Endoscopic Gastric Tubulization
Run by IHU Strasbourg · NCT03554902 · Data updated 2026-11-12
This study is testing a new, less invasive procedure to help adults with severe obesity lose weight and improve their quality of life by making their stomach smaller without surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | IHU Strasbourg Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | June 8, 2018 |
| Main results expected | June 2028 |
| Study ends | June 2028 |
| Registry record updated | May 1, 2025 |
| Trial ID | NCT03554902 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adult patients scheduled for endoscopic gastric tubulization at the Nouvel Hôpital Civil.
✕Probably not a fit
Patients who are not candidates for endoscopic procedures or those with contraindications to gastric tubulization may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the outcomes of endoscopic gastric tubulization in adult patients with morbid obesity at the Nouvel Hôpital Civil in Strasbourg, France. The procedure utilizes a specialized endoscopic suture device to reduce stomach size without incisions, aiming to achieve weight loss and improve quality of life. Data will be collected from patients before the procedure and up to two years post-procedure to assess weight loss, quality of life, and improvement in obesity-related comorbidities. The approach is designed to be less invasive than traditional bariatric surgery, with a focus on safety and reversibility.
Why it matters
Potential benefit: If successful, this procedure could provide a safer, less invasive option for significant weight loss and improved quality of life for patients with morbid obesity.
How similar studies have gone: Other studies have shown promising results with similar endoscopic approaches for weight loss, indicating potential for success in this novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients scheduled for an endoscopic gastric tubulization in the Nouvel Hôpital Civil, Strasbourg, France
Where it's running
-
Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil
Strasbourg, France Recruiting
Study contacts
- Principal investigator: Silvana Perretta, MD, PhD — Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil - Strasbourg
- Study coordinator: Silvana Perretta, MD, PhD
- Email: silvana.perretta@ircad.fr
- Phone: + 33 3 69 55 05 31
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
TSBL-based vs BMI-based limb length in one-anastomosis gastric bypass
This trial tests whether calculating the biliopancreatic limb length by total small bowel length (TSBL) helps weight loss and safety more than using standard BMI-based lengths in adults undergoing a single-center OAGB for obesity.
-
Gut stool tests after sleeve vs gastric bypass
This study tests whether routine stool tests can reveal changes in gut function six months after sleeve gastrectomy or gastric bypass in adults with morbid obesity.
-
Impact of Bariatric Surgery on Female Sexual Function and Hormones
This observational study will see how weight loss surgery affects sexual function and hormone levels in women with severe obesity, six months after surgery.
-
Dual-chamber patient-controlled pain relief after laparoscopic sleeve gastrectomy
This test checks whether a dual-chamber IV patient-controlled pump delivering fentanyl plus ketorolac reduces pain and postoperative nausea and vomiting in adults having laparoscopic sleeve gastrectomy.
-
Exercise program to improve weight, strength, and recovery around bariatric surgery
This program will test whether a structured exercise plan supported by telerehabilitation helps adults with severe obesity who are having bariatric surgery lose more body fat and gain more strength than usual care.
-
Comparing rivaroxaban and enoxaparin for preventing blood clots in obese patients undergoing weight loss surgery
This study tests whether the blood thinner rivaroxaban works better than enoxaparin to prevent blood clots in obese patients having weight loss surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.